Your browser doesn't support javascript.
loading
Temporary Extracorporeal Femoro-Femoral Crossover Bypass to Treat Acute Limb Ischemia due to Occlusive Femoral Transaortic Microaxial Left Ventricular Assist Device - A Novel Technique and Case Series.
Richarz, Sabine; Siegemund, Martin; d'Amico, Rosalinda; Bachofen, Bernadette; Döbele, Thomas; Gürke, Lorenz; Mujagic, Edin.
Afiliación
  • Richarz S; Department of Vascular Surgery, University Hospital Basel and University of Basel, Basel, Switzerland. Electronic address: Sabinejohanna.richarz@usb.ch.
  • Siegemund M; Department of Intensive Care Medicine, University Hospital Basel, Basel, Switzerland; Department of Clinical Research, University of Basel, Basel, Switzerland.
  • d'Amico R; Department of Vascular Surgery, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Bachofen B; Department of Vascular Surgery, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Döbele T; Department of Cardiac Surgery, University Hospital Basel, Basel, Switzerland.
  • Gürke L; Department of Vascular Surgery, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Mujagic E; Department of Vascular Surgery, University Hospital Basel and University of Basel, Basel, Switzerland.
Ann Vasc Surg ; 80: 379-385, 2022 Mar.
Article en En | MEDLINE | ID: mdl-34780943
BACKGROUND: The Impella transaortic microaxial left ventricular assist device (MLVAD) bears the risk of severe ipsilateral limb ischemia due to its percutaneous insertion through the common femoral artery (CFA). As long as the MLVAD is required for cardio - circulatory support, treatment options are limited. Therefore, we developed a temporary extracorporeal femoral - femoral crossover bypass to restore and maintain perfusion of the affected leg. METHODS: From October 2018, we treated all patients with severe limb ischemia due to the MLAVD with a femoral - femoral crossover bypass. For comparison, a consecutive cohort of patients undergoing placement of the MLAVD between January 2011 and October 2018 was identified. The primary outcome is the feasibility and safety of our percutaneously established extracorporeal femoral - femoral crossover bypass. RESULTS: Between January 2011 and July 2019, 25 of 245 (10.3%) patients developed a severe ipsilateral limb ischemia following the MLVAD placement. Until October 2018, 20 patients were treated conventionally (C - cohort) and since October 2018, five (consecutive) patients have been treated by an extracorporeal femoral - femoral cross over bypass (BP - Cohort). Following the BP - procedure, an immediate improvement of the perfusion was seen in all patients. Limb salvage was documented in 100% of our patients and 30 - day mortality was 60% in both groups. CONCLUSION: This is the first case series reporting on this novel technique. We demonstrated that the percutaneous creation of an extracorporeal crossover bypass is feasible, safe and effective and should therefore be promoted.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Corazón Auxiliar / Recuperación del Miembro / Extremidad Inferior / Arteria Femoral / Isquemia Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Vasc Surg Asunto de la revista: ANGIOLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Corazón Auxiliar / Recuperación del Miembro / Extremidad Inferior / Arteria Femoral / Isquemia Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Vasc Surg Asunto de la revista: ANGIOLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos